v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (4,637,982) $ (2,433,124)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 427 99,596
Amortization of right to use assets 38,940 34,064
Amortization of patent rights 153,449 153,450
Depreciation expense 138,588 94,281
Non-cash interest revenue (11,551) (26,280)
Loss on change in fair value of profit share 251,141 766,667
Changes in operating assets and liabilities    
Accounts receivable (436,489) (1,781,278)
Inventory (216,208) 123,645
Prepaid expenses (749,650) 67,956
Accrued salaries 16,819 (12,507)
Accounts payable and accrued liabilities (286,789) 1,488,022
Operating lease liability (37,565) (31,452)
Net cash used in operating activities (5,776,870) (1,456,960)
Cash flows used in investing activities    
Purchase of property and equipment (179,717) (23,395)
Net cash used in investing activities (179,717) (23,395)
Cash flows from financing activities    
Deferred offering costs 0 (207,500)
Proceeds from the issuance of common shares 16,440,000 0
Share issuance costs (1,730,133) 0
Repurchase of common shares (170,784) 0
Net cash provided by financing activities 14,539,083 (207,500)
Net increase (decrease) in cash and cash equivalents 8,582,496 (1,687,855)
Cash and cash equivalents - beginning of period 2,245,426 3,456,082
Cash and cash equivalents - end of period 10,827,922 1,768,227
Cash paid during the period for:    
Interest 0 0
Income taxes 3,766 15,173
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES    
Deferred financing costs reclassified to APIC upon issuance of common shares $ 481,250 $ 0

Source